Where to locate COVID-19 mass vaccination facilities?
Authors:
Dimitris Bertsimas,
Vassilis Digalakis Jr.,
Alexander Jacquillat,
Michael Lingzhi Li,
Alessandro Previero
Abstract:
The outbreak of COVID-19 led to a record-breaking race to develop a vaccine. However, the limited vaccine capacity creates another massive challenge: how to distribute vaccines to mitigate the near-end impact of the pandemic? In the United States in particular, the new Biden administration is launching mass vaccination sites across the country, raising the obvious question of where to locate these…
▽ More
The outbreak of COVID-19 led to a record-breaking race to develop a vaccine. However, the limited vaccine capacity creates another massive challenge: how to distribute vaccines to mitigate the near-end impact of the pandemic? In the United States in particular, the new Biden administration is launching mass vaccination sites across the country, raising the obvious question of where to locate these clinics to maximize the effectiveness of the vaccination campaign. This paper tackles this question with a novel data-driven approach to optimize COVID-19 vaccine distribution. We first augment a state-of-the-art epidemiological model, called DELPHI, to capture the effects of vaccinations and the variability in mortality rates across age groups. We then integrate this predictive model into a prescriptive model to optimize the location of vaccination sites and subsequent vaccine allocation. The model is formulated as a bilinear, non-convex optimization model. To solve it, we propose a coordinate descent algorithm that iterates between optimizing vaccine distribution and simulating the dynamics of the pandemic. As compared to benchmarks based on demographic and epidemiological information, the proposed optimization approach increases the effectiveness of the vaccination campaign by an estimated $20\%$, saving an extra $4000$ extra lives in the United States over a three-month period. The proposed solution achieves critical fairness objectives -- by reducing the death toll of the pandemic in several states without hurting others -- and is highly robust to uncertainties and forecast errors -- by achieving similar benefits under a vast range of perturbations.
△ Less
Submitted 18 July, 2021; v1 submitted 14 February, 2021;
originally announced February 2021.
From predictions to prescriptions: A data-driven response to COVID-19
Authors:
Dimitris Bertsimas,
LĂ©onard Boussioux,
Ryan Cory Wright,
Arthur Delarue,
Vassilis Digalakis Jr.,
Alexandre Jacquillat,
Driss Lahlou Kitane,
Galit Lukin,
Michael Lingzhi Li,
Luca Mingardi,
Omid Nohadani,
Agni Orfanoudaki,
Theodore Papalexopoulos,
Ivan Paskov,
Jean Pauphilet,
Omar Skali Lami,
Bartolomeo Stellato,
Hamza Tazi Bouardi,
Kimberly Villalobos Carballo,
Holly Wiberg,
Cynthia Zeng
Abstract:
The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a…
▽ More
The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic's spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and equitable vaccine distribution planning at a major pharmaceutical company, and have been integrated into the US Center for Disease Control's pandemic forecast.
△ Less
Submitted 29 June, 2020;
originally announced June 2020.